-
Taxonomy & unit
-
us-gaap: USD/shares
-
Description
-
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
-
Summary
-
Verve Therapeutics, Inc. quarterly/annual Earnings Per Share, Basic history and growth rate from Q3 2021 to Q3 2024.
- Verve Therapeutics, Inc. Earnings Per Share, Basic for the quarter ending September 30, 2024 was -0.59 USD/shares, a 18.1% increase year-over-year.
- Verve Therapeutics, Inc. Earnings Per Share, Basic for the twelve months ending September 30, 2024 was -2.46 USD/shares, a 20.4% increase year-over-year.
- Verve Therapeutics, Inc. annual Earnings Per Share, Basic for 2023 was -3.12 USD/shares, a 7.22% decline from 2022.
- Verve Therapeutics, Inc. annual Earnings Per Share, Basic for 2022 was -2.91 USD/shares, a 35% increase from 2021.
- Verve Therapeutics, Inc. annual Earnings Per Share, Basic for 2021 was -4.48 USD/shares, a 77.9% increase from 2020.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, YoY Quarterly Growth (%)